Breath, a new diagnostic pathway
Medlyse is developing a next-generation diagnostic solution that uses respiratory gas analysis and AI-based interpretation to detect diseases quickly and non-invasively.
The solution is designed to enable earlier, more informed clinical decision-making.
Breath reveals what the body hides
Medlyse technology analyzes breath in real time and painfree. This supports faster and more accurate decision-making.
Even the smallest breath says a lot
From newborns to the elderly, Medlyse’s solution covers the entire lifespan.
Current methods based on blood tests increase the risk of infections and are extremely painful for premature babies.
By detecting subtle changes in breathing, Medlyse can identify potential complications before they become critical.
The technology of breathing gas analysis
Medlyse’s technology analyses real time biomarkers from exhaled breath.
Our devices use state-of -the-art sensors to collect the biomarkers. The collected data is automatically run through artificial intelligence to identify various diseases at an early stage.
The method is painless and does not require laboratory tests.
Disease Library
Medlyse algorithms compare the Volatile Organic Compounds (VOC) profile of a patient's breath to a library of profiles of various disease states determined in clinical trials.
Let's work together
Partner with us to develop our clinical piloting, software platform or distribution network.